Abstract: The present invention relates to mucosal vaccine adjuvants containing flagellins, the structural component of flagella, originated from Vibrio vulnificus, Salmonella typhimurium, and Listeria monocytogenes as an active component.
Type:
Application
Filed:
January 12, 2005
Publication date:
March 20, 2008
Applicant:
CHONNAM NATONAL UNIVERSITY
Inventors:
Joon-Haeng Rhee, Shee-Eun Lee, Soo-Young Kim